Q2 2025 Holdings
Filed 2025-08-14 | 30 holdings | $455.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $43.6M | 2,341,667 | 9.6% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $42.4M | 1,946,054 | 9.3% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $31.9M | 337,000 | 7.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $29.1M | 12,592,500 | 6.4% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $23.6M | 1,350,000 | 5.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $22.6M | 18,350,000 | 5.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $22.5M | 2,425,000 | 4.9% |
| Merus N V | COM | N5749R100 | $20.5M | 389,000 | 4.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $20.1M | 3,672,000 | 4.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $19.8M | 2,763,000 | 4.4% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $19.4M | 3,820,000 | 4.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $15.6M | 903,500 | 3.4% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $15.0M | 7,691,334 | 3.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $14.5M | 905,000 | 3.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $14.4M | 1,273,333 | 3.2% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $13.8M | 2,130,000 | 3.0% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $13.5M | 1,030,000 | 3.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $11.8M | 672,595 | 2.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $11.6M | 266,000 | 2.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.7M | 1,267,000 | 2.1% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $9.3M | 1,018,021 | 2.0% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $7.7M | 1,115,000 | 1.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $7.0M | 148,000 | 1.5% |
| Unicycive Therapeutics Inc(UNCY) | COM NEW | 90466Y202 | $4.8M | 1,000,000 | 1.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $4.5M | 303,000 | 1.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.7M | 250,000 | 0.6% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $2.2M | 177,667 | 0.5% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $961.2K | 360,000 | 0.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $889.0K | 700,000 | 0.2% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $300.5K | 154,112 | 0.1% |